Paratek Pharmaceuticals Inc

VANGUARD GROUP INC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

2,228,066

Value ($000)

4,924

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	4,924	0.0%	2,228,066	6/30/2023
2023 Q1	7/14/2023	5,659	0.0%	2,228,066	3/31/2023
2022 Q4	2/10/2023	4,112	0.0%	2,199,148	12/31/2022
2022 Q3	11/14/2022	5,589	0.0%	2,174,625	9/30/2022
2022 Q2	8/12/2022	3,898	0.0%	2,019,686	6/30/2022
2022 Q1	5/13/2022	6,768	0.0%	2,278,878	3/31/2022
2021 Q4	2/14/2022	9,706	0.0%	2,161,773	12/31/2021
2021 Q3	11/12/2021	10,506	0.0%	2,161,818	9/30/2021
2021 Q2	8/13/2021	14,667	0.0%	2,150,521	6/30/2021
2021 Q1	5/14/2021	15,494	0.0%	2,194,665	3/31/2021
2020 Q4	2/12/2021	13,873	0.0%	2,216,128	12/31/2020
2020 Q3	11/16/2020	11,155	0.0%	2,061,906	9/30/2020
2020 Q2	8/14/2020	9,434	0.0%	1,807,152	6/30/2020
2020 Q1	5/15/2020	4,808	0.0%	1,526,673	3/31/2020
2019 Q4	2/14/2020	5,557	0.0%	1,378,882	12/31/2019